BRAFTOVI combination regimen is the first and only targeted therapy approvedby the U.S. FDA for treatment-naïve patients with metastatic colorectal cancer with a BRAF V600E mutation
Modernization and supply chain diversity drive new growth
Financing includes new funding from leading global organizations Eli Lilly and Company and EDBI
MedTech Mitra initiative aims to empower MedTech innovators and advance healthcare solutions
He advocated for a "PPP + PPP" collaboration, urging the public and private sectors within India to partner with their counterparts in other countries
The discussion at the fourth session was centered on the fusion of academic rigor and industrial pragmatism as a key to pioneering solutions for sustainable and prosperous future
Operationally ready by 2029, it will be the Company’s first-ever facility to cover the full manufacturing process for ADCs
The CRDMO site will add 120,000L manufacturing capacity to WuXi Biologics’ global network
World HRD Congress is a well-known international body of Management Studies
Subscribe To Our Newsletter & Stay Updated
